Conshohocken-based AmerisourceBergen took the opportunity during its annual investor day in New York on June 1 to outline five strategic imperatives for the company’s long-term sustainable growth, writes John George for the Philadelphia Business Journal.

In the future, the company plans to lead with market leaders, which it will achieve by fortifying long-term, strategic partnerships with its anchor customers.

AmerisourceBergen also plans to leverage infrastructure to increase efficiency as well as to support its customers in meeting consumer needs. This will involve using both its scale and capabilities to serve customers better.

Additionally the company wants to expand on leadership in specialty pharmaceuticals, including capturing the opportunities that will emerge as pharmaceutical innovation continues to advance.

Contributing to pharmaceutical outcomes by working collaboratively with partners both up and down the supply stream is also one of the imperatives.

Finally, the company plans to invest in innovation to further drive differentiation.

“Our business model generates sustainable and growing free cash flow, and this long-range plan includes a strengthening balance sheet, improving credit metrics, and increasing firepower for further potential share repurchases and strategic M&A opportunities,” said James F. Cleary, AmerisourceBergen executive vice president and chief financial officer.

Read more about AmerisourceBergen partnerships in the Philadelphia Business Journal.